Symrise

Last updated January 31, 2026

Innovation Areas

829

Inventors

Collaborations

Liposomal retinoid replacement matrix: SymriseRecent Research Landscape

Skin irritation and delayed efficacy of traditional retinoids drive consumer churn, which is mitigated by integrating instant-acting optical brighteners with non-irritating bio-retinol alternatives. This dual-action approach provides immediate visual correction while maintaining long-term therapeutic benefits without the typical side effects of pure retinol.

What technical problems is Symrise addressing in Liposomal retinoid replacement matrix?

Visible light induced hyperpigmentation

(4)evidences

Retinoids cause significant irritation and PTGS2-mediated inflammatory responses during dermatological treatment. Addressing this limitation allows for effective skin therapy without the adverse side effects that typically lead to patient non-compliance.

Insufficient topical pigment suppression

(1)evidences

Suboptimal light reflection and natural pigment irregularities create a dull or aged appearance. Immediate visual correction of these optical deficiencies provides an instant aesthetic improvement over slow-acting biological treatments.